LY2090314 is a potent GSK-3 inhibitor for GSK-3alpha/beta with IC50 of 1.5 nM/0.9 nM, may improve the efficacy of platinum-based chemotherapy regimens. Phase 1/2.
Molecular Weight:
512.53
Purity:
>99.0%
CAS Number:
[603288-22-8]
Formula:
C28H25FN6O3
Target:
GSK-3
* VAT and and shipping costs not included. Errors and price changes excepted